1. Home
  2. DSS vs PBM Comparison

DSS vs PBM Comparison

Compare DSS & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSS
  • PBM
  • Stock Information
  • Founded
  • DSS 1984
  • PBM 1994
  • Country
  • DSS United States
  • PBM Canada
  • Employees
  • DSS N/A
  • PBM N/A
  • Industry
  • DSS Containers/Packaging
  • PBM
  • Sector
  • DSS Consumer Discretionary
  • PBM
  • Exchange
  • DSS Nasdaq
  • PBM NYSE
  • Market Cap
  • DSS 7.3M
  • PBM 5.3M
  • IPO Year
  • DSS N/A
  • PBM N/A
  • Fundamental
  • Price
  • DSS $0.94
  • PBM $1.23
  • Analyst Decision
  • DSS
  • PBM
  • Analyst Count
  • DSS 0
  • PBM 0
  • Target Price
  • DSS N/A
  • PBM N/A
  • AVG Volume (30 Days)
  • DSS 17.5K
  • PBM 489.1K
  • Earning Date
  • DSS 03-26-2025
  • PBM 02-02-2025
  • Dividend Yield
  • DSS N/A
  • PBM N/A
  • EPS Growth
  • DSS N/A
  • PBM N/A
  • EPS
  • DSS N/A
  • PBM N/A
  • Revenue
  • DSS $25,019,000.00
  • PBM N/A
  • Revenue This Year
  • DSS N/A
  • PBM N/A
  • Revenue Next Year
  • DSS N/A
  • PBM N/A
  • P/E Ratio
  • DSS N/A
  • PBM N/A
  • Revenue Growth
  • DSS N/A
  • PBM N/A
  • 52 Week Low
  • DSS $0.77
  • PBM $1.16
  • 52 Week High
  • DSS $2.30
  • PBM $323.25
  • Technical
  • Relative Strength Index (RSI)
  • DSS 55.58
  • PBM 34.72
  • Support Level
  • DSS $0.77
  • PBM $1.22
  • Resistance Level
  • DSS $0.97
  • PBM $1.59
  • Average True Range (ATR)
  • DSS 0.08
  • PBM 0.20
  • MACD
  • DSS 0.01
  • PBM 0.01
  • Stochastic Oscillator
  • DSS 75.36
  • PBM 7.95

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: